914 related articles for article (PubMed ID: 18304147)
1. A study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD).
Shaw M; Morrell DS; Goldsmith LA
Pediatr Dermatol; 2008; 25(1):19-24. PubMed ID: 18304147
[TBL] [Abstract][Full Text] [Related]
2. Pediatric atopic eczema: the impact of an educational intervention.
Grillo M; Gassner L; Marshman G; Dunn S; Hudson P
Pediatr Dermatol; 2006; 23(5):428-36. PubMed ID: 17014636
[TBL] [Abstract][Full Text] [Related]
3. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
[TBL] [Abstract][Full Text] [Related]
4. Eczema workshops reduce severity of childhood atopic eczema.
Moore EJ; Williams A; Manias E; Varigos G; Donath S
Australas J Dermatol; 2009 May; 50(2):100-6. PubMed ID: 19397561
[TBL] [Abstract][Full Text] [Related]
5. An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants' Dermatitis Quality of Life Index and Dermatitis Family Impact score.
Beattie PE; Lewis-Jones MS
Br J Dermatol; 2006 Dec; 155(6):1249-55. PubMed ID: 17107397
[TBL] [Abstract][Full Text] [Related]
6. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
7. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
McKenna SP; Whalley D; de Prost Y; Staab D; Huels J; Paul CF; van Assche D
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a new moisturizer (Exomega milk) in children with atopic dermatitis.
Giordano-Labadie F; Cambazard F; Guillet G; Combemale P; Mengeaud V
J Dermatolog Treat; 2006; 17(2):78-81. PubMed ID: 16766330
[TBL] [Abstract][Full Text] [Related]
9. [Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life].
Sunderkötter C; Weiss JM; Bextermöller R; Löffler H; Schneider D
J Dtsch Dermatol Ges; 2006 Apr; 4(4):301-6. PubMed ID: 16638059
[TBL] [Abstract][Full Text] [Related]
10. Belgian observational drug utilization study of pimecrolimus cream 1% in routine daily practice in atopic dermatitis.
De Backer M; Morren MA; Boonen H; Boyden B; Vertruyen A; Lecomte P; Paquay C; Lesaffre E; Lambert J
Dermatology; 2008; 217(2):156-63. PubMed ID: 18525202
[TBL] [Abstract][Full Text] [Related]
11. Childhood atopic dermatitis: a measurement of quality of life and family impact.
Aziah MS; Rosnah T; Mardziah A; Norzila MZ
Med J Malaysia; 2002 Sep; 57(3):329-39. PubMed ID: 12440273
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist.
Schuttelaar ML; Vermeulen KM; Drukker N; Coenraads PJ
Br J Dermatol; 2010 Jan; 162(1):162-70. PubMed ID: 19849695
[TBL] [Abstract][Full Text] [Related]
13. The effect of dermatology consultations in secondary care on treatment outcome and quality of life in new adult patients with atopic dermatitis.
Baron SE; Morris PK; Dye L; Fielding D; Goulden V
Br J Dermatol; 2006 May; 154(5):942-9. PubMed ID: 16634899
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of tacrolimus ointment for atopic dermatitis in pediatric patients.
Yan J; Chen SL; Wang XL; Zhou W; Wang FS
Pediatr Dermatol; 2008; 25(1):117-20. PubMed ID: 18304172
[TBL] [Abstract][Full Text] [Related]
15. Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): correlations with quality of life, coping behaviour and SCORAD severity in 823 children.
Weisshaar E; Diepgen TL; Bruckner T; Fartasch M; Kupfer J; Lob-Corzilius T; Ring J; Scheewe S; Scheidt R; Schmid-Ott G; Schnopp C; Staab D; Szcepanski R; Werfel T; Wittenmeier M; Wahn U; Gieler U
Acta Derm Venereol; 2008; 88(3):234-9. PubMed ID: 18480921
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of an educational program in an "Atopic School": pilot study in 40 patients].
Chavigny JM; Adiceom F; Bernier C; Debons M; Stalder JF
Ann Dermatol Venereol; 2002; 129(8-9):1003-7. PubMed ID: 12442097
[TBL] [Abstract][Full Text] [Related]
17. Validation of a Mexican Spanish version of the Children's Dermatology Life Quality Index.
Ramírez-Anaya M; Macías ME; Velázquez-González E
Pediatr Dermatol; 2010; 27(2):143-7. PubMed ID: 20537063
[TBL] [Abstract][Full Text] [Related]
18. A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis.
Bissonnette R; Maari C; Provost N; Bolduc C; Nigen S; Rougier A; Seite S
J Cosmet Dermatol; 2010 Mar; 9(1):16-21. PubMed ID: 20367668
[TBL] [Abstract][Full Text] [Related]
19. [Observational study to evaluate the impact of an educational/informative intervention in the emotional status (anxiety) of patients with atopic dermatitis (CUIDA-DEL)].
Guerra-Tapia A; Lleonart M; Balañá M
Actas Dermosifiliogr; 2007 May; 98(4):250-8. PubMed ID: 17506956
[TBL] [Abstract][Full Text] [Related]
20. Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life.
Coutanceau C; Stalder JF
Dermatology; 2014; 229(3):248-55. PubMed ID: 25196258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
